The ALIGN Act is critical to ensure U.S. companies can continue to invest in tools and provide Americans with valued goods.
The Future of American Aerospace
The shift in U.S. space policy to open up opportunities for new innovative companies has resulted in increased competition and significant savings for taxpayers.
Tobacco Harm Reduction Products Should Be Widely Adopted
CAGW’s latest issue brief analyzes tobacco harm reduction strategies worldwide.
Pharmaceutical Price Controls are Bad Medicine
Price controls will result in increased drug prices, less innovation, and fewer new drugs.
CAGW Sends “Pharmaceutical Price Controls are Bad Medicine” to Congress
Drug price controls will threaten medical innovation, reduce research and development, and cost American jobs.
TITLE
i AM DOING THIS FOR A CMS LINK
CCAGW Urges New York Governor Kathy Hochul to Veto S3762 and S3556
The bills would seriously harm the ability of pharmacy benefit managers (PBMs) to use a variety of tools and policies that help lower drug costs.
CAGW Sends 2021 Prime Cuts to Congress
The 2021 Prime Cuts Report is not only required reading, it is also a roadmap for the bold action needed to restore fiscal sanity.
2021 Prime Cuts
Prime Cuts 2021 is a comprehensive list of proposals that should be adopted to reduce the record national debt.
CAGW Sends “Government-Run Healthcare Will Harm Patients and Eliminate Consumer Choice” to Congress
The best solution for healthcare reform is a free-market system that ensures individuals make their own choices.